Welcome to BioReagent Hub Hotline:19920083827
Article Detail

Protein Microarray Technology Explained: Types, Workflow, and Applications in Biomarker Research

AI Generated
2026-09-24 20:36 Author:ABIOP Source:AI 生成 Views 121
Back to List
Protein Microarray Technology Explained: Types, Workflow, and Applications in Biomarker Research

Technical Basis and Common Classifications of Protein Microarrays

Protein microarrays involve immobilizing multiple proteins, antibodies, or affinity capture molecules in microarray format on the surface of a solid support, enabling parallel detection of multiple proteins through the binding of target proteins in the test sample to capture molecules. Compared with single-protein detection, protein microarrays can simultaneously provide relatively rich information on protein expression or interactions in a single experiment, and are therefore commonly used in exploratory research and multi-indicator analysis.

By carrier type, common protein microarrays include slide-based microarrays, membrane-based microarrays, and bead-based suspension microarrays. Slide-based microarrays are suitable for use with fluorescence-labeled detection systems, and the array density is generally relatively high; membrane-based microarrays are relatively simple to operate and are suitable for chemiluminescence or colorimetric development; bead-based suspension microarrays distinguish detection items through differently encoded beads, providing a compromise between throughput and flexibility. By detection purpose, they can also be divided into antibody microarrays, antigen microarrays, reverse-phase protein microarrays, and functional protein microarrays. Antibody microarrays mainly use known antibodies to capture proteins in samples; antigen microarrays immobilize antigens for detecting antibodies in samples; reverse-phase protein microarrays spot cell or tissue lysates and then detect them with specific antibodies.

General Workflow in Marker Screening

In disease marker screening, protein microarrays are often used to compare differences in protein expression among different sample groups. The general workflow includes: sample preparation and quality control, microarray blocking and optimization of blocking conditions, sample incubation, washing, detection signal acquisition, and data analysis. Sample types can include serum, plasma, cell culture supernatant, or tissue lysate, among others, and the dilution factor and buffer system for different samples need to be determined based on the microarray manufacturer's recommendations and preliminary experiments.

Data analysis can use methods such as normalization, differential expression screening, and cluster analysis. Because microarray detection is affected by batch, spotting position, and individual sample differences, research designs usually require replicate microarrays, technical replicates, and biological replicates, combined with validation by other methods such as ELISA or immunoblotting. Protein microarray results are more suitable as a preliminary screening tool for candidate markers and should not be used alone as the basis for diagnostic conclusions.

Common Points of Attention in Experimental Operation

Protein microarrays have high requirements for operational consistency. Insufficient blocking may cause increased background, insufficient washing may lead to nonspecific binding signals, and uneven spotting may affect quantitative comparison. Before the experiment, the specificity and cross-reactivity risk of antibodies should be confirmed, and the linear range should be evaluated through preliminary experiments. Storage conditions also need attention; most protein microarrays are recommended to be stored dry at low temperature, avoiding repeated freeze-thaw cycles.

Overall, protein microarrays provide an efficient platform for multi-indicator protein analysis, but interpretation of their results needs to be combined with biological context and validation experiments. With the continuous improvement of microarray fabrication processes and data analysis methods, the application of protein microarrays in basic research, exploration of disease mechanisms, and discovery of candidate markers will become more mature.

Comments0

Sign in to comment on this article

✉Email 💬Message 👤Member
↑Top